Open on a desktop browser to explore the interactive map. The knowledge graph needs a larger screen and a pointer. On this device you are limited to the text below.
Dr. Ronald Roth Acu-Cell AI

Strontium Ranelate (Protelos / Osseor) Cardiovascular Safety Warning

EMEA / EMA Regulatory Actions and Heart Risks

  • Restricted Indication: Use is strictly limited to the treatment of severe osteoporosis in postmenopausal women and adult men at high risk of fracture.
  • Absolute Contraindications:
  • Current or previous heart disease (such as ischemic heart disease, peripheral arterial disease, or cerebrovascular disease).
  • Uncontrolled hypertension (high blood pressure).
  • Key Cardiovascular Risks: Clinical data showed a significant increase in the risk of myocardial infarction (heart attack) and venous thromboembolism (blood clots).
  • Monitoring Requirements: Physicians must evaluate a patient's cardiovascular risk before starting treatment and regularly reassess every 6 months. Treatment must be stopped immediately if the patient develops heart disease, ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
AI-generated in the approach of Dr. Ronald Roth. Not his own words.
Traversing graph…
Connections

Strontium ranelate - connections

Strontium ranelate ->

-> Strontium ranelate

Symptomatic drug therapy - connections

Symptomatic drug therapy ->

Cardiovascular disease - connections

Cardiovascular disease ->

-> Cardiovascular disease

Overview
Loading graph...
Display TOP 100%
Loading full knowledge graph…
Building graph…
Preparing…
Filter by Relationship
Filter by Type
Some information may be incomplete, disputed, or incorrect. Review the supporting sources.